{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:32:50Z","timestamp":1794439970395,"version":"4.9.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"am","delay-in-days":330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["20AA2005"],"award-info":[{"award-number":["20AA2005"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jns.2023.120742","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T18:49:08Z","timestamp":1690224548000},"page":"120742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Associations between neuromyelitis optica spectrum disorder, Sj\u00f6gren's syndrome, and conditions with electrolyte disturbances"],"prefix":"10.1016","volume":"452","author":[{"given":"Tetsuya","family":"Akaishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Tarasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pulukool","family":"Sandhya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Misu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juichi","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Yaegashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Fujihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2023.120742_bb0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120742_bb0010","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1007\/s00415-017-8596-7","article-title":"What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients","volume":"264","author":"Hamid","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2023.120742_bb0015","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120742_bb0020","article-title":"Incidence of AQP4-IgG seropositive neuromyelitis optica spectrum disorders in the Netherlands: about one in a million","volume":"2","author":"Dani\u00eblle van Pelt","year":"2016","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1016\/j.jns.2023.120742_bb0025","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bpa.12084","article-title":"Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature","volume":"23","author":"Jarius","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jns.2023.120742_bb0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/WNO.0000000000000508","article-title":"Neuromyelitis Optica: deciphering a complex immune-mediated Astrocytopathy","volume":"37","author":"Bennett","year":"2017","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.jns.2023.120742_bb0035","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.neuroscience.2009.11.062","article-title":"Functional and molecular interactions between aquaporins and Na,K-ATPase","volume":"168","author":"Illarionova","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2023.120742_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2016.06.002","article-title":"The role of AQP4 in neuromyelitis optica: more answers, more questions","volume":"298","author":"Yang","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2023.120742_bb0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.7224\/1537-2073.2016-077","article-title":"Case report: osmotic demyelination syndrome in an adolescent with Neuromyelitis Optica","volume":"20","author":"Kariv","year":"2018","journal-title":"Int J MS Care"},{"key":"10.1016\/j.jns.2023.120742_bb0050","article-title":"Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: a national population-based study","volume":"2","author":"Tian","year":"2020","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.jns.2023.120742_bb0055","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1590\/0004-282X20140097","article-title":"Sj\u00f6gren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu","volume":"72","author":"Carvalho","year":"2014","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.jns.2023.120742_bb0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00296-014-3066-3","article-title":"Neuromyelitis optica spectrum disorders associated with other autoimmune diseases","volume":"35","author":"Freitas","year":"2015","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jns.2023.120742_bb0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/sni.sni_224_18","article-title":"Comprehensive review of neuromyelitis optica and clinical characteristics of neuromyelitis optica patients in Puerto Rico","volume":"9","author":"Zarei","year":"2018","journal-title":"Surg. Neurol. Int."},{"key":"10.1016\/j.jns.2023.120742_bb0070","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00415-020-10377-6","article-title":"Impact of comorbid Sj\u00f6gren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders","volume":"268","author":"Akaishi","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2023.120742_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103494","article-title":"Clinical significance of anti-SSA\/Ro antibody in Neuromyelitis optica spectrum disorders","volume":"58","author":"Lin","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jns.2023.120742_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.969762","article-title":"Comparative analysis of clinical and imaging data of first-attack neuromyelitis optica spectrum disorders with and without connective tissue disease","volume":"13","author":"Yao","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2023.120742_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33552\/ANN.2019.06.000626","article-title":"SSA positivity as predictor of relapse in patients with neuromyelitis optica spectrum disorder","volume":"6","author":"Cruz","year":"2019","journal-title":"Arch Neurol Neurosci"},{"key":"10.1016\/j.jns.2023.120742_bb0090","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/art.38100","article-title":"Clinically significant renal involvement in primary Sj\u00f6gren\u2019s syndrome: clinical presentation and outcome","volume":"65","author":"Goules","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2023.120742_bb0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/1874312901408010103","article-title":"Sj\u00f6gren\u2019s, renal tubular acidosis and osteomalacia - an Asian Indian series","volume":"8","author":"Sandhya","year":"2014","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.jns.2023.120742_bb0100","article-title":"A novel association of osmotic demyelination in Sj\u00f6gren\u2019s syndrome prompts revisiting role of aquaporins in CNS demyelinating diseases: a literature review","volume":"69","author":"Sandhya","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jns.2023.120742_bb0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ane.12938","article-title":"Hyponatremia in neuromyelitis optica spectrum disorders: literature review","volume":"138","author":"Jin","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2023.120742_bb0110","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0140-6736(21)00986-7","article-title":"Syndrome of inappropriate antidiuretic hormone secretion and hypothalamic hypocortisolism in neuromyelitis optica","volume":"397","author":"Tsagkas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2023.120742_bb0115","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1212\/WNL.0b013e3182343377","article-title":"Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica","volume":"77","author":"Iorio","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120742_bb0120","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s40001-022-00949-9","article-title":"Clinical analysis of neuromyelitis optica spectrum disease with area postrema syndrome as the initial symptom","volume":"27","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.jns.2023.120742_bb0125","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1681\/ASN.V7122527","article-title":"Coexistence of central diabetes insipidus and salt wasting: the difficulties in diagnosis, changes in natremia, and treatment","volume":"7","author":"Laredo","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jns.2023.120742_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5049\/EBP.2020.18.1.19","article-title":"Recurrent severe hyponatremia in a patient with Sj\u00f6gren\u2019s syndrome","volume":"18","author":"Kim","year":"2020","journal-title":"Electrolyte Blood Press"},{"key":"10.1016\/j.jns.2023.120742_bb0135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nrneph.2015.174","article-title":"Renal involvement in primary Sj\u00f6gren syndrome","volume":"12","author":"Fran\u00e7ois","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jns.2023.120742_bb0140","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1536\/ihj.46.855","article-title":"Impact of the Japanese diagnosis procedure combination-based payment system on cardiovascular medicine-related costs","volume":"46","author":"Yasunaga","year":"2005","journal-title":"Int. Heart J."},{"key":"10.1016\/j.jns.2023.120742_bb0145","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.je.2016.09.009","article-title":"Validity of diagnoses, procedures, and laboratory data in Japanese administrative data","volume":"27","author":"Yamana","year":"2017","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jns.2023.120742_bb0150","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jiac.2022.06.013","article-title":"Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: a retrospective cohort study","volume":"28","author":"Endo","year":"2022","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.jns.2023.120742_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2188\/jea.JE20200288","article-title":"History and profile of diagnosis procedure combination (DPC): development of a real data collection system for acute inpatient care in Japan","volume":"31","author":"Hayashida","year":"2021","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jns.2023.120742_bb0160","series-title":"ICD-10: international statistical classification of diseases and related health problems : tenth revision [\u200eelectronic resource]\u200e","author":"World Health Organization","year":"2005"},{"key":"10.1016\/j.jns.2023.120742_bb0165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing--when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jns.2023.120742_bb0170","author":"R Core Team (R Foundation for Statistical Computing)"},{"key":"10.1016\/j.jns.2023.120742_bb0175","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001145","article-title":"The clinical characteristics of primary Sjogren\u2019s syndrome with neuromyelitis optica spectrum disorder in China: a STROBE-compliant article","volume":"94","author":"Qiao","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jns.2023.120742_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113392","article-title":"Involvement of Aquaporins in the pathogenesis, diagnosis and treatment of Sj\u00f6gren\u2019s syndrome","volume":"19","author":"Soyfoo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2023.120742_bb0185","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1177\/0022034517717965","article-title":"Functional epitopes for anti-aquaporin 5 antibodies in Sj\u00f6gren syndrome","volume":"96","author":"Alam","year":"2017","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.jns.2023.120742_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8111863","article-title":"Associations of anti-aquaporin 5 autoantibodies with serologic and histopathological features of Sj\u00f6gren\u2019s syndrome","volume":"8","author":"Jeon","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jns.2023.120742_bb0195","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/rheumatology\/kex328","article-title":"Antibodies to aquaporins are frequent in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"56","author":"Tzartos","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jns.2023.120742_bb0200","doi-asserted-by":"crossref","first-page":"G1081","DOI":"10.1152\/ajpgi.00449.2005","article-title":"A naturally occurring point mutation in the rat aquaporin 5 gene, influencing its protein production by and secretion of water from salivary glands","volume":"291","author":"Murdiastuti","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jns.2023.120742_bb0205","doi-asserted-by":"crossref","first-page":"20071","DOI":"10.1074\/jbc.274.29.20071","article-title":"Defective secretion of saliva in transgenic mice lacking aquaporin-5 water channels","volume":"274","author":"Ma","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jns.2023.120742_bb0210","doi-asserted-by":"crossref","first-page":"23413","DOI":"10.1074\/jbc.M008760200","article-title":"Salivary acinar cells from aquaporin 5-deficient mice have decreased membrane water permeability and altered cell volume regulation","volume":"276","author":"Krane","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jns.2023.120742_bb0215","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2174\/157015910791233178","article-title":"Aquaporins and glia","volume":"8","author":"Albertini","year":"2010","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jns.2023.120742_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074773","article-title":"Anti-aquaporin-1 autoantibodies in patients with neuromyelitis optica spectrum disorders","volume":"8","author":"Tzartos","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2023.120742_bb0225","doi-asserted-by":"crossref","first-page":"100","DOI":"10.23876\/j.krcp.2017.36.1.100","article-title":"Syndrome of inappropriate antidiuretic hormone secretion associated with seronegative neuromyelitis optica spectrum disorder","volume":"36","author":"Oh","year":"2017","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.jns.2023.120742_bb0230","article-title":"Diabetes insipidus: pathogenesis, diagnosis, and clinical management","volume":"13","author":"Mutter","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jns.2023.120742_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2282","article-title":"AQP4-IgG positive paraneoplastic NMOSD: a case report and review","volume":"11","author":"Ding","year":"2021","journal-title":"Brain Behav"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23002034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23002034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:02:06Z","timestamp":1758384126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X23002034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":47,"alternative-id":["S0022510X23002034"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2023.120742","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between neuromyelitis optica spectrum disorder, Sj\u00f6gren's syndrome, and conditions with electrolyte disturbances","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2023.120742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120742"}}